In light of previous data suggesting racially disparate access to and quality of allergy care,20 this raises the possibility that some of the excess burden of convincing milk allergy observed among specific US racial/ethnic minority populations may be attributable to systematic lack of access to follow-up care, including routine monitoring of specific IgE values for evidence of tolerance development and conducting oral food challenges when clinically indicated. The gene discussed is IGHE; the disease is allergic disease.